Back to Rankings

IRD

Opus GeneticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
IRD vs peer average
17/100
IRD vs. peer average (F vs. C)
Grade spread
A 1 · B 5 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BEAM is the first available peer comparator.

Precision genetic medicines company—shared dependence on platform scalability and financing for trials.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBEAMBeam Therapeutics
IRD
Opus Genetics
BEAM
Beam Therapeutics
Grade
F
B
Momentum
45
76
Value
41
41
Sentiment
0
66
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs BEAM

IRD / BEAM
Grade Position
Below peers
IRD vs. peer average (F vs. C)
17/100
Momentum
45
BEAM
Value
41
IRD
Sentiment
0
BEAM

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IRD
1
BEAM
BEAM
B
80/100
-3
2
CRSP
CRSP
B
80/100
-3
3
EDIT
EDIT
B
80/100
-3
4
ABEO
Abeona Therapeutics Inc Common
B
80/100
-3
5
NMRA
Neumora Therapeutics Inc Common
A
100/100
-4
BEAM is the first peer returned for this comparison set.